|
|
Clinical effect study of Octreotide combined with Thrombin treating cirrhosis complicated with upper gastrointestinal bleeding |
ZHOU Xiao-yu |
Department of Gastroenterology,Qidong People′s Hospital in Jiangsu Province,Qidong 226200,China |
|
|
Abstract ObjectiveTo study the clinical effect of Octreotide combined with Thrombin treating cirrhosis complicated with upper gastrointestinal bleeding.MethodsA total of 60 patients with cirrhosis complicated with upper gastrointestinal bleeding treated in our hospital from December 2014 to December 2016 were selected.By drawing lots,they were divided into two groups.Regular treatment like nutritional support was provided in both groups.Besides,in the control group(n=30),Octreotide was provided,and in the observation group(n=30),Octreotide combined with Thrombin was applied.The success rate of hemostasis,average hospital stay,rebleeding rate and mean hemostatic time were compared between the two groups.ResultsThe average hemostasis time in the observation group was (18.3±3.3)h,and it was less than that in the control group[(27.6±4.0)h](P<0.05).The average hospital stay in the observation group was(7.2±2.9)d and was shorter than the control group[(9.6±5.6)d](P<0.05).The success rate of hemostasis in the observation group was 100.00%,and it was much higher than that in the control group accounting for 73.33%(P<0.05).The rebleeding rate in the observation group was 3.33%,and it was greatly lower than that in the control group accounting for 26.67% (P<0.05).ConclusionOctreotide combined with Thrombin treating cirrhosis complicated with upper gastrointestinal bleeding has a great effect,and it can obviously shorten the hemostasis time,decrease the rate of rebleeding,and improve the success rate of hemostasis.
|
|
|
|
|
[1] |
侯昀.肝硬化不同病因上消化道出血患者的临床对比[J].临床和实验医学杂志,2015,14(12):999-1001.
|
[2] |
邓淑凯.奥曲肽联合凝血酶治疗肝硬化合并上消化道出血的临床疗效观察[J].实用临床医药杂志,2015,19(13):111-112.
|
[3] |
李亚兰.奥曲肽联合凝血酶治疗肝硬化合并上消化道出血的疗效观察[J].中国民族民间医药,2016,25(12):77.
|
[4] |
李海琴.奥曲肽联合凝血酶治疗肝硬化合并上消化道出血的疗效[J].白求恩医学杂志,2014,41(1):91-92.
|
[5] |
王汝刚,张伟,李晓栋,等.肝硬化合并消化道出血患者的临床影响因素分析[J].中国当代医药,2016,23(4):20-22,25.
|
[6] |
李达斌,吴成周,贺彩霞,等.生长抑素联合垂体后叶素治疗肝硬化并发上消化道大出血的疗效分析[J].中国医学创新,2012,9(17):37-38.
|
[7] |
王建华.奥曲肽与凝血酶联合治疗肝硬化合并上消化道出血的临床分析[J].中国卫生标准管理,2016,7(5):84-85.
|
[8] |
李宜华.奥曲肽联合泮托拉唑治疗胃、十二指肠溃疡出血的临床应用价值[J].中国当代医药,2014,21(11):75-76,79.
|
[9] |
黄达.奥曲肽与凝血酶治疗肝硬化并上消化道出血的临床随机对照研究[J].齐齐哈尔医学院学报,2016,37(25):3132-3134.
|
[10] |
王家芳,肖承文.奥曲肽与垂体后叶素治疗肝硬化上消化道出血的临床效果比较[J].中国当代医药,2014,21(28):71-72,75.
|
[11] |
毛华云.醋酸奥曲肽联合硝酸甘油治疗肝硬化继发上消化道出血的临床效果观察[J].中国当代医药,2015,22(1):106-108.
|
[12] |
郭华先.奥曲肽配伍凝血酶治疗肝硬化合并上消化道出血的临床效果分析[J].河南医学研究,2016,25(3):518-519.
|
[13] |
游祖红.奥曲肽配伍凝血酶治疗肝硬化合并上消化道出血的临床疗效评价[J].世界临床医学,2016,10(20):114-115.
|
[14] |
姜帆.奥曲肽联合埃索美拉唑治疗肝硬化上消化道出血的疗效观察[J].中国继续医学教育,2016,8(4):172-173.
|
[15] |
吴波,彭乐平,唐海芸.奥曲肽联合泮托拉唑治疗肝硬化合并上消化道出血的疗效观察[J].临床合理用药杂志,2016,9(28):58-59.
|
|
|
|